Signalling pathways mediating inflammatory responses in brain ischaemia
- 25 October 2006
- journal article
- review article
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 34 (6) , 1267-1270
- https://doi.org/10.1042/bst0341267
Abstract
Stroke causes neuronal necrosis and generates inflammation. Pro-inflammatory molecules intervene in this process by triggering glial cell activation and leucocyte infiltration to the injured tissue. Cytokines are major mediators of the inflammatory response. Pro-inflammatory and anti-inflammatory cytokines are released in the ischaemic brain. Anti-inflammatory cytokines, such as interleukin-10, promote cell survival, whereas pro-inflammatory cytokines, such as TNFalpha (tumour necrosis factor alpha), can induce cell death. However, deleterious effects of certain cytokines can turn to beneficial actions, depending on particular features such as the concentration, time point and the very intricate network of intracellular signals that become activated and interact. A key player in the intracellular response to cytokines is the JAK (Janus kinase)/STAT (signal transducer and activator of transcription) pathway that induces alterations in the pattern of gene transcription. These changes are associated either with cell death or survival depending, among other things, on the specific proteins involved. STAT1 activation is related to cell death, whereas STAT3 activation is often associated with survival. Yet, it is clear that STAT activation must be tightly controlled, and for this reason the function of JAK/STAT modulators, such as SOCS (suppressors of cytokine signalling) and PIAS (protein inhibitor of activated STAT), and phosphatases is most relevant. Besides local effects in the ischaemic brain, cytokines are released to the circulation and affect the immune system. Unbalanced pro-inflammatory and anti-inflammatory plasma cytokine concentrations favouring an 'anti-inflammatory' state can decrease the immune response. Robust evidence now supports that stroke can induce an immunodepression syndrome, increasing the risk of infection. The contribution of individual cytokines and their intracellular signalling pathways to this response needs to be further investigated.Keywords
This publication has 50 references indexed in Scilit:
- Inflammatory biomarkers in blood of patients with acute brain ischemiaEuropean Journal of Neurology, 2006
- Tumor Necrosis Factor-α Neutralization Reduced Cerebral Edema Through Inhibition of Matrix Metalloproteinase Production After Transient Focal Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 2005
- Blockade of interleukin‐6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neuronsJournal of Neurochemistry, 2005
- The many faces of tumor necrosis factor in strokeNature Medicine, 2002
- Cytokine and Cytokine Receptor Pleiotropy and RedundancyJournal of Biological Chemistry, 2002
- Inflammation-Mediated Damage in Progressing Lacunar InfarctionsStroke, 2002
- Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in strokeCell Death & Differentiation, 2001
- Attenuation and augmentation of ischaemia‐related neuronal death by tumour necrosis factor‐α in vitroEuropean Journal of Neuroscience, 2000
- Proinflammatory Cytokines and Early Neurological Worsening in Ischemic StrokeStroke, 2000
- Cerebral Interleukin-6 is Neuroprotective during Permanent Focal Cerebral Ischemia in the RatJournal of Cerebral Blood Flow & Metabolism, 1998